Skip to main content
. 2024 May 12;16(5):e60141. doi: 10.7759/cureus.60141

Table 1. Summary of the key findings of the case.

S100: a protein family that's soluble in 100% ammonium sulphate at a neutral pH; CD: cluster of differentiation; AE1/3: antibody cocktail used to indicate carcinomas; SMA: spinal muscular atrophy; Pax5: a B-cell specific activator protein; Mum1: multiple myeloma oncogene-1

Key Findings
Presenting Symptoms Chronic back pain with progressive weakness in bilateral lower limbs.
Review of Systems Denied fever, loss of consciousness, and headaches.
Red Flags Progressive weakness with recent rapid deterioration, nonambulatory, young age, bilateral leg numbness, micturition difficulty, increased constipation, and loss of sensation below T10.
Imaging Contrast-enhanced MRI of the spine.
Diagnosis Spinal cord compression secondary to unknown mass lesion.
Treatment Laminectomy and thoracic spinal cord decompression with lesion excision.
In-House Pathology Results Unknown etiology, non-neoplastic cyst with mixed lymphoplasmacytic and histiocytic infiltrate.
Mayo Clinic Pathology Results Unknown etiology, non-neoplastic cyst with mixed lymphoplasmacytic and histiocytic infiltrate.
(+) Biomarkers S100 and CD68.
(-) Biomarkers AE1/3, CD20, SMA, Pax5, CD30, CD15, Mum1, CD34, CD3, Desmin, Langerin, and CD1a.